LBS.01
心力衰竭和房顫：維生素、礦物質、營養素等
時間：11月13日，10:30 AM - 11:30 AM
研究1：Omecamtiv Mecarbil In Chronic Heart Failure With Reduced Ejection Fraction: The Global Approach To Lowering Adverse Cardiac Outcomes Through Improving Contractility In Heart Failure (GALACTIC-HF) Trial
GALACTIC-HF研究：Omecamtiv Mecarbil治療射血分數降低的慢性心力衰竭：通過改善心力衰竭患者的心肌收縮力來降低不良心臟結局的全球方法研究
研究2：Ferric Carboxymaltose In Iron Deficient Patients Admitted For Acute Heart Failure
AFFIRM-AHF研究：羧基麥芽糖鐵用於治療因急性心力衰竭入院的鐵缺乏患者
研究3：The Vital Rhythm Trial: Omega-3 Fatty Acid And Vitamin D Supplementation In The Primary Prevention Of Atrial Fibrillation
Vital Rhythm研究：使用Omega-3脂肪酸和維生素D補充劑用於房顫一級預防
LBS.02
彎曲的心血管疾病曲線——精準還是複方製劑？
時間：11月13日，12:00 PM - 1:00 PM
研究1：A Polypill For Primary Prevention Of Cardiovascular Disease In Intermediate Risk People: Results Of The International Polycap Study (TIPS)-3
TIPS-3研究：一種用於中危心血管疾病患者一級預防的複方製劑
研究2：Aspirin Alone And In Combination With A Polypill In Cardiovascular Disease Primary Prevention: Results From The International Polycap Study (TIPS)-3
TIPS-3研究：阿司匹林單藥治療或與複方製劑聯合用藥，以進行心血管疾病一級預防
研究3：Prevalence And Prediction Of Coronary Artery Disease In The General Population- Results From The Swedish Cardiopulmonary Bioimage Study (scapis)
SCAPIS研究：普通人群冠狀動脈疾病的患病率和預測
LBS.03
目前冠心病和瓣膜疾病面臨的挑戰
時間：11月14日，12:00 PM - 1:00 PM
研究1：Ticagrelor Versus Clopidogrel In Elective Percutaneous Coronary Intervention : The Alpheus Trial
ALPHEUS研究：在進行擇期經皮冠脈介入治療的患者中，對比替格瑞洛與氯吡格雷的療效
研究2：Coronary Oct And Cardiac Mri To Determine Underlying Causes Of Minoca In Women
HARP-MINOCA研究：使用冠脈OCT和心臟MRI診斷女性冠狀動脈非阻塞型心肌梗死（MINOCA）的潛在病因
研究3：Oral Anti-xa Anticoagulation After Trans-aortic Valve Implantation For Aortic Stenosis: The Randomized Atlantis Trial
Atlantis研究：在經主動脈瓣植入術後口服抗Xa因子抗凝藥物進行治療
LBS.04
脂質管理中的魚油、花式藥物及挫折感
時間：11月15日，9:00 AM - 10:00 AM
研究1：STRENGTH Trial: Cardiovascular Outcomes With Omega-3 Carboxylic Acids (Epanova) In Patients With High Vascular Risk And Atherogenic Dyslipidemia
STRENGTH研究：在高血管風險和致動脈粥樣硬化血脂異常患者中，應用Omega-3羧酸（Epanova）的心血管結局
研究2：Effects Of N-3 Fatty Acid Supplements On Clinical Outcome After Myocardial Infarction In The Elderly: Results Of The Omemi Trial
OMEMI研究：N-3脂肪酸補充劑對老年患者心肌梗死後臨床結局的影響
研究3：A Three-arm N-of-1 Trial With Statin, Placebo And Tablet Free Periods, To Verify Side Effects And Identify Their Cause: The SAMSON Trial
SAMSON研究：他汀類藥物、安慰劑和無片劑期的三臂單病例隨機對照試驗（N-of-1 trial），以驗證不良反應並確定其原因
研究4：The Efficacy And Safety Of Evinacumab In Patients With Refractory Hypercholesterolemia
Evinacumab在難治性高膽固醇血癥患者中的療效和安全性
LBS.05
支架、瓣膜和血栓
時間：11月15日，7:30 PM - 8:30 PM
研究1：A Prospective Multicenter Randomized Controlled Trial Assessing The Safety And Efficacy Of The BuMA Supreme™ Biodegradable Drug Coated Coronary Stent System In Patients With Stable Or Non-ST Elevation Acute Coronary Syndromes: Primary Endpoint Results Of The PIONEER III Trial
PIONEER Ⅲ研究的主要終點結果：評估BuMA Supreme™生物可降解藥物塗層冠脈支架系統在穩定或非ST段抬高型急性冠脈綜合徵患者中安全性和有效性的前瞻性多中心隨機對照試驗
研究2：One Month Dual Antipletelet Therapy Followed By Aspirin Monotherapy After Drug Eluting Stent Implantation
在置入藥物洗脫支架後1個月內進行雙聯抗血小板治療，之後進行阿司匹林單藥治療的療效
研究3：Rivaroxaban Versus Warfarin In Patients With Bioprosthetic Mitral Valves And Atrial Fibrillation Or Flutter: Primary Results From The RIVER Randomized Trial
RIVER研究的初步結果：在植入人工二尖瓣的房顫/房撲患者中比較利伐沙班與華法林的療效
LBS.06
篩查還是不篩查？之後是什麼？房顫的檢測與治療研究
時間：11月16日，9:00 AM - 10:00 AM
研究1：Enhanced Monitoring For Atrial Fibrillation Following Cardiac Surgery: Primary Results Of The SEARCH-AF Cardiolink Randomized Trial
SEARCH-AF Cardiolink隨機試驗的初步結果：心臟手術後強化房顫監測
研究2：Screening For Atrial Fibrillation In Older Adults At Primary Care Visits Using Single Lead Electrocardiograms: The VITAL-AF Trial
VITAL-AF研究：在初級保健門診使用單導聯心電圖對老年人進行房顫篩查
研究3：3-year Clinical Outcomes In A Nationwide, Randomized, Pragmatic Clinical Trial Of Atrial Fibrillation Screening - Mhealth Screening To Prevent Strokes (mstops)
MSTOPS研究：全國性、隨機、實用的房顫篩查臨床試驗的3年臨床結果（預防卒中的Mhealth篩查）
研究4：Early Invasive Intervention For Atrial Fibrillation
LBS.07
腦、腎和心臟的隨機試驗
時間：11月16日， 7:10 PM - 8:30 PM
研究1：Finerenone And Cardiovascular Outcomes In Patients With Chronic Kidney Disease And Type 2 Diabetes
FIDELIO-DKD研究：在慢性腎臟病合併2型糖尿病患者中，應用非奈利酮的心血管結局
研究2：Ticagrelor Added To Aspirin In Acute Ischemic Stroke Or Tia Of Atherosclerotic Origin
THALES研究：在阿司匹林基礎上加用替格瑞洛，以治療源於動脈粥樣硬化的急性缺血性卒中或短暫性腦缺血發作
研究3：RHAPSODY: Rilonacept An IL-1α And IL-1β Trap Resolves Pericarditis Episodes And Reduces Risk Of Recurrence In A Phase 3 Trial Of Patients With Recurrent Pericarditis
RHAPSODY研究：心包炎復發患者的3期臨床試驗顯示，Rilonacept作為IL-1α 和 IL-1β Trap可降低心包炎發作及復發風險
研究4：Rapid Assessment Of Potential Ischaemic Heart Disease With Ctca: The Rapid-ctca Trial. A Randomised Trial Of Ctcain The Evaluation, Intervention And Outcome Of adults With Suspected or Confirmed Acute Coronary Syndrome Presenting To The Emergency Department
RAPID-CTCA研究：CTCA用於急診、可疑或確診急性冠脈綜合徵成人患者的缺血性心臟病的評估、干預和預後
研究5：SOLOIST-WHF: Sotagliflozin in Diabetes Patients with Recent Worsening Heart Failure
SOLOIST-WHF研究：索格列淨在近期心力衰竭惡化的糖尿病患者中的療效
研究6：SCORED: Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
SCORED研究：索格列淨在糖尿病合併慢性腎病患者中的療效
LBS.08
AHA熱點：COVID-19、流感疫苗和心血管疾病
時間：11月17日，9:00 AM - 10:00 AM
研究1：The AHA COVID-19 Cardiovascular Disease Registry: Design, Implementation, and Initial Results
AHA COVID-19心血管疾病註冊研究：設計、實施和初步結果
研究2：Racial and Ethnic Differences in Treatment and Outcomes for Patients Hospitalized with COVID-19: Findings from the American Heart Association COVID-19 Cardiovascular Disease Registry
AHA COVID-19心血管疾病註冊研究：COVID-19住院患者在治療和結局方面的種族差異
研究3：Association of Body Mass Index with Death, Mechanical Ventilation, and Cardiovascular Outcomes in COVID-19: Findings from the AHA COVID-19 Cardiovascular Disease Registry
AHA COVID-19心血管疾病註冊研究：在COVID-19患者中，體重指數與死亡、機械通氣及心血管結局的相關性
研究4：Impact Of Cardiovascular Disease On Outcomes Among Hospitalized COVID-19 Patients: Results From >14,000 Patients Across The United States
全美＞14000例患者的結果：心血管疾病對住院COVID-19患者結局的影響
研究5：High Dose Versus Standard Dose Influenza Vaccine In Patients With High Risk Cardiovascular Disease: Results From The Invested Trial
INVESTED研究：在高危心血管疾病患者中，高劑量與標準劑量流感疫苗的對比
LBS.09
高科技或高觸感：優化患者護理的創新策略
時間：11月17日，12:00 PM - 1:00 PM
研究1：An Electronically Delivered, Patient-activation Tool For Intensification Of Medications For Chronic Heart Failure With Reduced Ejection Fraction: The EPIC-HF Trial
EPIC-HF研究：一種用於強化射血分數降低的慢性心力衰竭藥物治療的電子傳遞、患者激活工具
研究2：My Recorded On-demand Audio Discharge Instructions(MyRoad) In Heart Failure
MYROAD研究：錄製的點播音頻放電說明（MyRoad）在心力衰竭中的應用
研究3：Digital Care Transformation: One-year Report Of >5,000 Patients Enrolled An A Remote Algorithm-based Cv Risk Management Program To Achieve Optimal Lipid And Hypertension Control
數字化醫療轉型：在＞5000例患者中，報告了基於遠程算法的心血管風險管理程序（實現最佳的脂質和高血壓控制）的1年報告
研究4：Group Medical Visits And Microfinance For Patients With Diabetes And Hypertension In Western Kenya: Results Of The BIGPIC Trial
BIGPIC研究：肯尼亞西部地區，糖尿病合併高血壓患者的團體醫療訪問和小額信貸
